These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 39174623)
1. Development of novel humanized VHH synthetic libraries based on physicochemical analyses. Nakakido M; Kinoshita S; Tsumoto K Sci Rep; 2024 Aug; 14(1):19533. PubMed ID: 39174623 [TBL] [Abstract][Full Text] [Related]
2. A novel heavy domain antibody library with functionally optimized complementarity determining regions. Mandrup OA; Friis NA; Lykkemark S; Just J; Kristensen P PLoS One; 2013; 8(10):e76834. PubMed ID: 24116173 [TBL] [Abstract][Full Text] [Related]
3. Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics. Murakami T; Kumachi S; Matsunaga Y; Sato M; Wakabayashi-Nakao K; Masaki H; Yonehara R; Motohashi M; Nemoto N; Tsuchiya M Antibodies (Basel); 2022 Jan; 11(1):. PubMed ID: 35225868 [TBL] [Abstract][Full Text] [Related]
4. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433 [TBL] [Abstract][Full Text] [Related]
5. A large human domain antibody library combining heavy and light chain CDR3 diversity. Chen W; Zhu Z; Feng Y; Dimitrov DS Mol Immunol; 2010 Jan; 47(4):912-21. PubMed ID: 19883941 [TBL] [Abstract][Full Text] [Related]
6. A single-domain antibody library based on a stability-engineered human VH3 scaffold. Lee NJ; Jung M; Yang HY; Shim H Sci Rep; 2024 Jul; 14(1):17747. PubMed ID: 39085444 [TBL] [Abstract][Full Text] [Related]
7. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies. Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464 [TBL] [Abstract][Full Text] [Related]
8. Global analysis of VHHs framework regions with a structural alphabet. Noël F; Malpertuy A; de Brevern AG Biochimie; 2016 Dec; 131():11-19. PubMed ID: 27613403 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-throughput sequencing. Miyazaki N; Kiyose N; Akazawa Y; Takashima M; Hagihara Y; Inoue N; Matsuda T; Ogawa R; Inoue S; Ito Y J Biochem; 2015 Sep; 158(3):205-15. PubMed ID: 25888581 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain. Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976 [TBL] [Abstract][Full Text] [Related]
11. Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn. Gong R; Wang Y; Ying T; Dimitrov DS PLoS One; 2012; 7(8):e42288. PubMed ID: 22879932 [TBL] [Abstract][Full Text] [Related]
12. Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies. Rouet R; Dudgeon K; Christie M; Langley D; Christ D J Biol Chem; 2015 May; 290(19):11905-17. PubMed ID: 25737448 [TBL] [Abstract][Full Text] [Related]
13. Lateral recognition of a dye hapten by a llama VHH domain. Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862 [TBL] [Abstract][Full Text] [Related]
14. On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality. Fernández-Quintero ML; Guarnera E; Musil D; Pekar L; Sellmann C; Freire F; Sousa RL; Santos SP; Freitas MC; Bandeiras TM; Silva MMS; Loeffler JR; Ward AB; Harwardt J; Zielonka S; Evers A Protein Sci; 2024 Nov; 33(11):e5176. PubMed ID: 39422475 [TBL] [Abstract][Full Text] [Related]
15. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. Barrios Y; Jirholt P; Ohlin M J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640 [TBL] [Abstract][Full Text] [Related]
16. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394 [TBL] [Abstract][Full Text] [Related]
17. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144 [TBL] [Abstract][Full Text] [Related]
18. A Two-Step Approach for the Design and Generation of Nanobodies. Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198 [TBL] [Abstract][Full Text] [Related]
19. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. Saerens D; Pellis M; Loris R; Pardon E; Dumoulin M; Matagne A; Wyns L; Muyldermans S; Conrath K J Mol Biol; 2005 Sep; 352(3):597-607. PubMed ID: 16095608 [TBL] [Abstract][Full Text] [Related]
20. An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop. Fanning SW; Horn JR Protein Sci; 2011 Jul; 20(7):1196-207. PubMed ID: 21557375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]